Review



exosome diagnosis  (Bio-Techne corporation)


Bioz Verified Symbol Bio-Techne corporation is a verified supplier
Bioz Manufacturer Symbol Bio-Techne corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    Bio-Techne corporation exosome diagnosis
    Exosome Diagnosis, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 463 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exosome+diagnosis/10__1016_slash_j__vesic__2023__100029-19-4-22?v=Bio-Techne+corporation
    Average 99 stars, based on 463 article reviews
    exosome diagnosis - by Bioz Stars, 2026-07
    99/100 stars

    Images



    Similar Products

    construction of microfluidic exosome chip for diagnosis of lung metastasis of osteosarcoma  (Exosome Diagnostics)
    86
    Exosome Diagnostics construction of microfluidic exosome chip for diagnosis of lung metastasis of osteosarcoma
    Integration of liquid biopsy and artificial intelligence for precision oncology Current and emerging applications of artificial intelligence (AI)-integrated exosome analysis in oncology. At present, exosomes isolated from various body fluids are profiled for molecular contents (nucleic acids, proteins, lipids), which are analyzed via AI algorithms to enable biomarker discovery, early cancer detection, and optimization of exosome-based therapeutics Future directions include the development of multimodal AI systems integrating exosomal multi-omics with clinical and imaging data to support intelligent diagnostic and prognostic platforms. AI-driven <t>microfluidic</t> devices will facilitate real-time exosome monitoring and standardized, large-scale analyses, ultimately advancing precision medicine
    Construction Of Microfluidic Exosome Chip For Diagnosis Of Lung Metastasis Of Osteosarcoma, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exosome+diagnosis/pmc12980980-50-0-3?v=Exosome+Diagnostics
    Average 86 stars, based on 1 article reviews
    construction of microfluidic exosome chip for diagnosis of lung metastasis of osteosarcoma - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    triad exosome axis diagnoses failure  (Exosome Diagnostics)
    86
    Exosome Diagnostics triad exosome axis diagnoses failure
    Integration of liquid biopsy and artificial intelligence for precision oncology Current and emerging applications of artificial intelligence (AI)-integrated exosome analysis in oncology. At present, exosomes isolated from various body fluids are profiled for molecular contents (nucleic acids, proteins, lipids), which are analyzed via AI algorithms to enable biomarker discovery, early cancer detection, and optimization of exosome-based therapeutics Future directions include the development of multimodal AI systems integrating exosomal multi-omics with clinical and imaging data to support intelligent diagnostic and prognostic platforms. AI-driven <t>microfluidic</t> devices will facilitate real-time exosome monitoring and standardized, large-scale analyses, ultimately advancing precision medicine
    Triad Exosome Axis Diagnoses Failure, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exosome+diagnosis/pmc12730715-730-2-2?v=Exosome+Diagnostics
    Average 86 stars, based on 1 article reviews
    triad exosome axis diagnoses failure - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    single test based diagnosis of multiple cancer types using exosome sers ai for early stage cancers  (Exosome Diagnostics)
    86
    Exosome Diagnostics single test based diagnosis of multiple cancer types using exosome sers ai for early stage cancers
    Integration of liquid biopsy and artificial intelligence for precision oncology Current and emerging applications of artificial intelligence (AI)-integrated exosome analysis in oncology. At present, exosomes isolated from various body fluids are profiled for molecular contents (nucleic acids, proteins, lipids), which are analyzed via AI algorithms to enable biomarker discovery, early cancer detection, and optimization of exosome-based therapeutics Future directions include the development of multimodal AI systems integrating exosomal multi-omics with clinical and imaging data to support intelligent diagnostic and prognostic platforms. AI-driven <t>microfluidic</t> devices will facilitate real-time exosome monitoring and standardized, large-scale analyses, ultimately advancing precision medicine
    Single Test Based Diagnosis Of Multiple Cancer Types Using Exosome Sers Ai For Early Stage Cancers, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exosome+diagnosis/pmc13050563-24-0-8?v=Exosome+Diagnostics
    Average 86 stars, based on 1 article reviews
    single test based diagnosis of multiple cancer types using exosome sers ai for early stage cancers - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    exosome based diagnosis  (Exosome Diagnostics)
    86
    Exosome Diagnostics exosome based diagnosis
    Integration of liquid biopsy and artificial intelligence for precision oncology Current and emerging applications of artificial intelligence (AI)-integrated exosome analysis in oncology. At present, exosomes isolated from various body fluids are profiled for molecular contents (nucleic acids, proteins, lipids), which are analyzed via AI algorithms to enable biomarker discovery, early cancer detection, and optimization of exosome-based therapeutics Future directions include the development of multimodal AI systems integrating exosomal multi-omics with clinical and imaging data to support intelligent diagnostic and prognostic platforms. AI-driven <t>microfluidic</t> devices will facilitate real-time exosome monitoring and standardized, large-scale analyses, ultimately advancing precision medicine
    Exosome Based Diagnosis, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exosome+diagnosis/10__1021_slash_acsnanomed__5c00056-333-2-2?v=Exosome+Diagnostics
    Average 86 stars, based on 1 article reviews
    exosome based diagnosis - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    exosome diagnosis  (Bio-Techne corporation)
    99
    Bio-Techne corporation exosome diagnosis
    Integration of liquid biopsy and artificial intelligence for precision oncology Current and emerging applications of artificial intelligence (AI)-integrated exosome analysis in oncology. At present, exosomes isolated from various body fluids are profiled for molecular contents (nucleic acids, proteins, lipids), which are analyzed via AI algorithms to enable biomarker discovery, early cancer detection, and optimization of exosome-based therapeutics Future directions include the development of multimodal AI systems integrating exosomal multi-omics with clinical and imaging data to support intelligent diagnostic and prognostic platforms. AI-driven <t>microfluidic</t> devices will facilitate real-time exosome monitoring and standardized, large-scale analyses, ultimately advancing precision medicine
    Exosome Diagnosis, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/exosome+diagnosis/10__1016_slash_j__vesic__2023__100029-19-4-22?v=Bio-Techne+corporation
    Average 99 stars, based on 1 article reviews
    exosome diagnosis - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Integration of liquid biopsy and artificial intelligence for precision oncology Current and emerging applications of artificial intelligence (AI)-integrated exosome analysis in oncology. At present, exosomes isolated from various body fluids are profiled for molecular contents (nucleic acids, proteins, lipids), which are analyzed via AI algorithms to enable biomarker discovery, early cancer detection, and optimization of exosome-based therapeutics Future directions include the development of multimodal AI systems integrating exosomal multi-omics with clinical and imaging data to support intelligent diagnostic and prognostic platforms. AI-driven microfluidic devices will facilitate real-time exosome monitoring and standardized, large-scale analyses, ultimately advancing precision medicine

    Journal: Molecular Cancer

    Article Title: Mechanisms of tumor-derived extracellular vesicle-mediated immunometabolic reprogramming and immunotherapeutic resistance

    doi: 10.1186/s12943-025-02556-8

    Figure Lengend Snippet: Integration of liquid biopsy and artificial intelligence for precision oncology Current and emerging applications of artificial intelligence (AI)-integrated exosome analysis in oncology. At present, exosomes isolated from various body fluids are profiled for molecular contents (nucleic acids, proteins, lipids), which are analyzed via AI algorithms to enable biomarker discovery, early cancer detection, and optimization of exosome-based therapeutics Future directions include the development of multimodal AI systems integrating exosomal multi-omics with clinical and imaging data to support intelligent diagnostic and prognostic platforms. AI-driven microfluidic devices will facilitate real-time exosome monitoring and standardized, large-scale analyses, ultimately advancing precision medicine

    Article Snippet: Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of Osteosarcoma , Completed , Osteosarcoma, lung metastases/Diagnosis and Prognosis , Enrollment number: 60 The association of disease recurrence with plasma levels of exosome and their subgroups , Start: 2020.10.1 Completion: 2022.9.30 , NCT05101655.

    Techniques: Isolation, Biomarker Discovery, Imaging, Diagnostic Assay, Clinical Proteomics